PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $39,501,000 | -5.1% | 167,300 | -24.0% | 6.10% | -4.9% |
| Q4 2014 | $41,639,000 | -65.6% | 220,000 | -56.7% | 6.42% | -74.2% |
| Q3 2014 | $121,074,000 | +784.1% | 507,500 | +144.6% | 24.90% | +586.2% |
| Q2 2014 | $13,695,000 | -36.6% | 207,500 | 0.0% | 3.63% | -27.0% |
| Q1 2014 | $21,609,000 | +4.4% | 207,500 | +3.8% | 4.97% | -17.3% |
| Q4 2013 | $20,706,000 | – | 200,000 | – | 6.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |